Why leading health systems are choosing to build and operate their own specialty pharmacy: the patient and financial benefits

Becker's Healthcare November 29, 2022
In collaboration with CPS

As specialty drugs become more common, the types and forms of these drugs are changing, and their costs are increasing.

For example, many new high-cost specialty drugs — even cancer drugs — can now be taken orally, in contrast to specialty drugs of the past that were administered via infusion in a hospital. In response, multiple stakeholders are racing to fill these prescriptions, including payers that are building out their own specialty pharmacies. These developments pose a significant strategic challenge to hospitals and health systems as they may be losing revenue from their infusion suites and seeing specialty prescriptions filled elsewhere.

At a workshop sponsored by CPS at the Becker’s 10^th Annual CEO + CFO Roundtable, Greg Wozniak, president and...

Today's Sponsors

Today's Sponsor